Third Rock Ventures Iii, L.p. - Net Worth and Insider Trading
Third Rock Ventures Iii, L.p. Net Worth
The estimated net worth of Third Rock Ventures Iii, L.p. is at least $134 Million dollars as of 2024-11-13. Third Rock Ventures Iii, L.p. is the 10% Owner of MyoKardia Inc and owns about 221,042 shares of MyoKardia Inc (MYOK) stock worth over $50 Million. Third Rock Ventures Iii, L.p. is the 10% Owner of Relay Therapeutics Inc and owns about 7,739,918 shares of Relay Therapeutics Inc (RLAY) stock worth over $46 Million. Third Rock Ventures Iii, L.p. is also the 10% Owner of Fulcrum Therapeutics Inc and owns about 5,962,202 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $22 Million. Besides these, Third Rock Ventures Iii, L.p. also holds Jounce Therapeutics Inc (JNCE) , Revolution Medicines Inc (RVMD) , Voyager Therapeutics Inc (VYGR) . Details can be seen in Third Rock Ventures Iii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Third Rock Ventures Iii, L.p. has not made any transactions after 2023-02-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Third Rock Ventures Iii, L.p.
Third Rock Ventures Iii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Third Rock Ventures Iii, L.p. owns 12 companies in total, including Revolution Medicines Inc (RVMD) , Nurix Therapeutics Inc (NRIX) , and Relay Therapeutics Inc (RLAY) among others .
Click here to see the complete history of Third Rock Ventures Iii, L.p.’s form 4 insider trades.
Insider Ownership Summary of Third Rock Ventures Iii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RVMD | Revolution Medicines Inc | 2022-06-08 | 10 percent owner |
| NRIX | Nurix Therapeutics Inc | 2020-07-23 | 10 percent owner |
| RLAY | Relay Therapeutics Inc | 2021-01-14 | 10 percent owner |
 | | 2020-06-02 | 10 percent owner |
| | 2019-07-22 | 10 percent owner |
| | 2023-02-01 | 10 percent owner |
| | 2018-06-29 | 10 percent owner |
| | 2018-01-03 | 10 percent owner |
| | 2016-11-14 | 10 percent owner |
| | 2021-11-12 | 10 percent owner |
| | 2016-02-02 | 10 percent owner |
| | 2021-02-11 | 10 percent owner |
Third Rock Ventures Iii, L.p. Latest Holdings Summary
Third Rock Ventures Iii, L.p. currently owns a total of 6 stocks. Among these stocks, Third Rock Ventures Iii, L.p. owns 221,042 shares of MyoKardia Inc (MYOK) as of January 3, 2018, with a value of $50 Million and a weighting of 37.04%. Third Rock Ventures Iii, L.p. owns 7,739,918 shares of Relay Therapeutics Inc (RLAY) as of January 14, 2021, with a value of $46 Million and a weighting of 34.26%. Third Rock Ventures Iii, L.p. also owns 5,962,202 shares of Fulcrum Therapeutics Inc (FULC) as of July 22, 2019, with a value of $22 Million and a weighting of 16.22%. The other 3 stocks Jounce Therapeutics Inc (JNCE) , Revolution Medicines Inc (RVMD) , Voyager Therapeutics Inc (VYGR) have a combined weighting of 12.49% among all his current holdings.
Latest Holdings of Third Rock Ventures Iii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MYOK | MyoKardia Inc | 2018-01-03 | 221,042 | 224.91 | 49,714,556 |
| RLAY | Relay Therapeutics Inc | 2021-01-14 | 7,739,918 | 5.94 | 45,975,113 |
| FULC | Fulcrum Therapeutics Inc | 2019-07-22 | 5,962,202 | 3.65 | 21,762,037 |
| JNCE | Jounce Therapeutics Inc | 2021-11-12 | 4,698,661 | 1.88 | 8,833,483 |
| RVMD | Revolution Medicines Inc | 2022-06-08 | 129,258 | 59.36 | 7,672,755 |
| VYGR | Voyager Therapeutics Inc | 2023-02-01 | 36,701 | 6.83 | 250,668 |
Holding Weightings of Third Rock Ventures Iii, L.p.
Third Rock Ventures Iii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Third Rock Ventures Iii, L.p. has made a total of 0 transactions in MyoKardia Inc (MYOK) over the past 5 years. The most-recent trade in MyoKardia Inc is the sale of 816,326 shares on January 3, 2018, which brought Third Rock Ventures Iii, L.p. around $34 Million.
According to the SEC Form 4 filings, Third Rock Ventures Iii, L.p. has made a total of 1 transactions in Relay Therapeutics Inc (RLAY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Relay Therapeutics Inc is the sale of 5,622,394 shares on January 14, 2021, which brought Third Rock Ventures Iii, L.p. around $227 Million.
According to the SEC Form 4 filings, Third Rock Ventures Iii, L.p. has made a total of 0 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years. The most-recent trade in Fulcrum Therapeutics Inc is the acquisition of 81,250 shares on July 22, 2019, which cost Third Rock Ventures Iii, L.p. around $1 Million.
More details on Third Rock Ventures Iii, L.p.'s insider transactions can be found in the Insider Trading History of Third Rock Ventures Iii, L.p. table.Insider Trading History of Third Rock Ventures Iii, L.p.
- 1
Third Rock Ventures Iii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Third Rock Ventures Iii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Third Rock Ventures Iii, L.p. is -59.61%. GuruFocus also compares Third Rock Ventures Iii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Third Rock Ventures Iii, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Third Rock Ventures Iii, L.p.'s insider trading performs compared to the benchmark.
Performance of Third Rock Ventures Iii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.3 | | | | | |
| Relative Return to S&P 500(%) | -7.22 | | | | | |
Third Rock Ventures Iii, L.p. Ownership Network
Ownership Network List of Third Rock Ventures Iii, L.p.
Ownership Network Relation of Third Rock Ventures Iii, L.p.
Third Rock Ventures Iii, L.p. Owned Company Details
What does Revolution Medicines Inc do?
Who are the key executives at Revolution Medicines Inc?
Third Rock Ventures Iii, L.p. is the 10 percent owner of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include General Counsel Jeff Cislini , director & See Remarks Mark A Goldsmith , and See Remarks Stephen Michael Kelsey .
Revolution Medicines Inc (RVMD) Insider Trades Summary
Over the past 18 months, Third Rock Ventures Iii, L.p. made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 34,044 shares made by Jeff Cislini , a net sale of 186,391 shares made by Stephen Michael Kelsey , and a net sale of 265,672 shares made by Mark A Goldsmith .
In summary, during the past 3 months, insiders sold 249,942 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 249,942 shares. During the past 18 months, 718,995 shares of Revolution Medicines Inc (RVMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 718,995 shares.
Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revolution Medicines Inc Insider Transactions
Third Rock Ventures Iii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Third Rock Ventures Iii, L.p.. You might contact Third Rock Ventures Iii, L.p. via mailing address: 29 Newbury Street, 3rd Floor, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
